சீர்குலைக்கும் தொழில்நுட்பம் விருது News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from சீர்குலைக்கும் தொழில்நுட்பம் விருது. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In சீர்குலைக்கும் தொழில்நுட்பம் விருது Today - Breaking & Trending Today

Baebies Awarded $2.7 Million NIH Grant for Rapid, Near-patient Heparin Monitoring Requiring Low Sample Volume

Baebies Awarded $2.7 Million NIH Grant for Rapid, Near-patient Heparin Monitoring Requiring Low Sample Volume
pittsburghstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pittsburghstar.com Daily Mail and Mail on Sunday newspapers.

United States , North Carolina , Emily Mcloughlin , Ronald Warren , Sitaram Emani , National Institutes Of Health , Division Of Blood Diseases , Disruptive Technology Award , Baebies Inc , Cardiovascular Program Coagulation Laboratory , Systems Blood Science Branch , National Heart , Blood Institute , National Institutes , Boston Children , Surgical Director , Adult Congenital Heart Program , Blood Diseases , Technology Award , Medical Device Excellence Awards , ஒன்றுபட்டது மாநிலங்களில் , வடக்கு கரோலினா , எமிலி ம்க்லோயூஃப்லிந் , ரொனால்ட் வாரன் , தேசிய நிறுவனங்கள் ஆஃப் ஆரோக்கியம் , பிரிவு ஆஃப் இரத்தம் நோய்கள் ,

Baebies, Inc.: Baebies Awarded $2.7 Million NIH Grant for Rapid, Near-patient Heparin Monitoring Requiring Low Sample Volume

(1)
DURHAM, NC / ACCESSWIRE / May 19, 2021 / Baebies, a growth-stage company developing innovative products to enable early disease detection and multifunctional diagnostics for syndromic testing, was recently awarded $2.7 million in a Phase IIB SBIR grant from the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health (NIH). This award supports validation, clinical evaluation, and FDA submission of a rapid test panel for near-patient heparin monitoring. This project is a continuation of a long-standing collaboration with Boston Children s Hospital to develop a low blood volume platform for heparin monitoring particularly for neonates and pediatric patients.
Heparin is an anticoagulant prescribed to patients at high risk for thrombosis or who are being treated for conditions requiring anti-coagulant therapy such as those with congenital heart defects or other hospitalized patients. A patient who undergoes cardiac surgery will invariably be p ....

United States , North Carolina , Kostenloser Wertpapierhandel , Emily Mcloughlin , Ronald Warren , Sitaram Emani , National Institutes Of Health , Division Of Blood Diseases , Disruptive Technology Award , Baebies Inc , Cardiovascular Program Coagulation Laboratory , Systems Blood Science Branch , National Heart , Blood Institute , National Institutes , Boston Children , Surgical Director , Adult Congenital Heart Program , Blood Diseases , Technology Award , Medical Device Excellence Awards , ஒன்றுபட்டது மாநிலங்களில் , வடக்கு கரோலினா , எமிலி ம்க்லோயூஃப்லிந் , ரொனால்ட் வாரன் , தேசிய நிறுவனங்கள் ஆஃப் ஆரோக்கியம் ,

Baebies Awarded $2.7 Million NIH Grant for Rapid, Near-patient Heparin Monitoring Requiring Low Sample Volume

Baebies Awarded $2.7 Million NIH Grant for Rapid, Near-patient Heparin Monitoring Requiring Low Sample Volume
ACCESSWIRE
20 May 2021, 02:55 GMT+10
DURHAM, NC / ACCESSWIRE / May 19, 2021 /Baebies, a growth-stage company developing innovative products to enable early disease detection and multifunctional diagnostics for syndromic testing, was recently awarded $2.7 million in a Phase IIB SBIR grant from the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health (NIH). This award supports validation, clinical evaluation, and FDA submission of a rapid test panel for near-patient heparin monitoring. This project is a continuation of a long-standing collaboration with Boston Children s Hospital to develop a low blood volume platform for heparin monitoring particularly for neonates and pediatric patients. ....

United States , North Carolina , Emily Mcloughlin , Ronald Warren , Sitaram Emani , National Institutes Of Health , Division Of Blood Diseases , Disruptive Technology Award , Baebies Inc , Cardiovascular Program Coagulation Laboratory , Systems Blood Science Branch , National Heart , Blood Institute , National Institutes , Boston Children , Surgical Director , Adult Congenital Heart Program , Blood Diseases , Technology Award , Medical Device Excellence Awards , ஒன்றுபட்டது மாநிலங்களில் , வடக்கு கரோலினா , எமிலி ம்க்லோயூஃப்லிந் , ரொனால்ட் வாரன் , தேசிய நிறுவனங்கள் ஆஃப் ஆரோக்கியம் , பிரிவு ஆஃப் இரத்தம் நோய்கள் ,

Baebies Awarded up to $11.6 Million from CARB-X for the Development of a Diagnostic Platform with Rapid Results for Sepsis

/ April 20, 2021 /
Baebies, a growth-stage company developing innovative products to enable early disease detection and comprehensive diagnosis, announced today that CARB-X has awarded the company up to $11.6 million in non-dilutive funding. This funding will support the development of a near-patient and rapid diagnostic platform for sepsis - specially focused on addressing the unique needs of neonatal and pediatric populations.
The CARB-X award consists of $3.9 million in initial funding with up to $7.7 million of milestone-based funding. CARB-X, a global non-profit partnership, provides funding and support for projects that target drug-resistant bacteria deemed Serious or Urgent on the U.S. Centers for Disease Control and Prevention (CDC) Antibiotic Resistant Threats list or Critical or High on the World Health Organization s Priority Bacterial Pathogens list. ....

North Carolina , United States , United Kingdom , Emily Mcloughlin , Vamsee Pamula , Richard West , Us Centers For Disease , Boston University School Of Law , National Institute Of Allergy , Melinda Gates Foundation , Baebies Inc , Us Department Of Health , United Kingdom Department Of Health , Care Global Antimicrobial Resistance Innovation Fund , World Health Organization Priority Bacterial Pathogens , Biomedical Advanced Research , Human Services , Boston University , Disruptive Technology Award , Development Authority , Germany Federal Ministry Of Education , United Kingdom Government Department Of Health , Office Of The , Us National Institutes Of Health , Disease Control , Antibiotic Resistant Threats ,

Baebies Awarded up to $11.6 Million from CARB-X for the Development of a Diagnostic Platform with Rapid Results for Sepsis

Baebies Awarded up to $11.6 Million from CARB-X for the Development of a Diagnostic Platform with Rapid Results for Sepsis
phoenixherald.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from phoenixherald.com Daily Mail and Mail on Sunday newspapers.

North Carolina , United States , United Kingdom , Emily Mcloughlin , Vamsee Pamula , Richard West , Us Centers For Disease , Boston University School Of Law , National Institute Of Allergy , Melinda Gates Foundation , Baebies Inc , Us Department Of Health , United Kingdom Department Of Health , Care Global Antimicrobial Resistance Innovation Fund , World Health Organization Priority Bacterial Pathogens , Biomedical Advanced Research , Human Services , Boston University , Disruptive Technology Award , Development Authority , Germany Federal Ministry Of Education , United Kingdom Government Department Of Health , Office Of The , Us National Institutes Of Health , Disease Control , Antibiotic Resistant Threats ,